ArticleRMD open2023
The wide range of opportunities for large language models such as ChatGPT in rheumatology.
Article in RMD open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Structured prompting as reusable clinical tools.EULAR rheumatology open · 2026Article
- Artificial Intelligence (AI) in rheumatology: a comparative evaluation of the ChatGPT and DeepSeek application.BMC rheumatology · 2026Article
- Artificial Intelligence in Rheumatology: From Algorithms to Clinical Impact in Osteoporosis and Chronic Inflammatory Rheumatic Diseases.Journal of clinical medicine · 2026Article
- What Large Language Models offer about Familial Mediterranean Fever: An Analysis of Quality, Readability, Completeness, and Accuracy.Mediterranean journal of rheumatology · 2025Article
- Evaluation of the Performance of Large Language Models in the Management of Axial Spondyloarthropathy: Analysis of EULAR 2022 Recommendations.Diagnostics (Basel, Switzerland) · 2025Article
- Assessing the value of artificial intelligence-based image analysis for pre-operative surgical planning of neck dissections and iENE detection in head and neck cancer patients.Discover oncology · 2025Article
- Artificial intelligence for image recognition in diagnosing oral and oropharyngeal cancer and leukoplakia.Scientific reports · 2025Article
- Assessing the use of the novel tool Claude 3 in comparison to ChatGPT 4.0 as an artificial intelligence tool in the diagnosis and therapy of primary head and neck cancer cases.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024Article
- Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study.Rheumatology international · 2024Article
- Development and evaluation of a text analytics algorithm for automated application of national COVID-19 shielding criteria in rheumatology patients.Annals of the rheumatic diseases · 2024Article
- Advancing Rheumatology Care Through Machine Learning.Pharmaceutical medicine · 2024Article
- Advancing AI in rheumatology: critical reflections and proposals for future research using large language models.Rheumatology international · 2024Article
- Large language models: rheumatologists' newest colleagues?Nature reviews. Rheumatology · 2024Article
- Diagnostic accuracy of a large language model in rheumatology: comparison of physician and ChatGPT-4.Rheumatology international · 2024Article
- A Systematic Review and Meta-Analysis of Artificial Intelligence Tools in Medicine and Healthcare: Applications, Considerations, Limitations, Motivation and Challenges.Diagnostics (Basel, Switzerland) · 2024Review
- Assessing the role of advanced artificial intelligence as a tool in multidisciplinary tumor board decision-making for recurrent/metastatic head and neck cancer cases - the first study on ChatGPT 4o and a comparison to ChatGPT 4.0.Frontiers in oncology · 2024Article
- Assessing the role of advanced artificial intelligence as a tool in multidisciplinary tumor board decision-making for primary head and neck cancer cases.Frontiers in oncology · 2024Article
- Artificial intelligence in rheumatology: status quo and quo vadis-results of a national survey among German rheumatologists.Therapeutic advances in musculoskeletal disease · 2024Article
- Harnessing ChatGPT and GPT-4 for evaluating the rheumatology questions of the Spanish access exam to specialized medical training.Scientific reports · 2023Article
- Digital transformation of an academic hospital department: A case study on strategic planning using the balanced scorecard.PLOS digital health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.